The “Great Debate” at Immunotherapy Bridge 2021, December 1st–2nd, 2021

The “Great Debate” at Immunotherapy Bridge 2021, December 1st–2nd, 2021

Abstract As part of the 2021 Immunotherapy Bridge virtual congress (December 1–2, Naples, Italy), the Great Debate sessions featured experts who were assigned counter opposing views on four important questions in immunotherapy today. The first topic was whether oncolytic viruses or other specific im...

Full description

Bibliographic Details
Main Authors: Paolo A. Ascierto, Lisa H. Butterfield, Olivera J. Finn, Andrew Futreal, Omid Hamid, Theresa LaVallee, Michael A. Postow, Igor Puzanov, Jeffrey Sosman, Bernard A. Fox, Patrick Hwu
Format: Article
Language:English
Published: BMC 2022-04-01
Series:Journal of Translational Medicine
Subjects:
Immunotherapy
Cancer vaccine
Checkpoint inhibitors
Nivolumab
Pembrolizumab
Overall survival
Online Access:https://doi.org/10.1186/s12967-022-03384-w

Internet

https://doi.org/10.1186/s12967-022-03384-w

Similar Items